Your cart is empty.
Männedorf, Switzerland, April 06, 2011 – Euroscreen S.A., a pre-clinical drug discovery company based in Gosselies, Belgium, has chosen Tecan’s flexible Infinite® F200 PRO multimode plate reader for a variety of screening applications in drug discovery and characterization. Specializing in G-protein coupled receptors (GPCRs), Euroscreen provides high throughput screening and drug development services globally, relying on Tecan’s Infinite F200 PRO to ensure high quality results across its broad range of assays, as well as Tango™ GPCR and HTRF® assays.
Laurent Meeus, a research scientist at Euroscreen, explained: “We develop and run numerous assays in support of our clients drug development activities, requiring a reader with a great deal of flexibility to accommodate the varying needs of each project. The Infinite F200 PRO offers excellent performance and value, as well as benefiting from Tecan’s high quality technical support, and using the reader in conjunction with our Tecan liquid handling workstation saves a lot of time per assay. It combines ease of use with fast measurements and good reproducibility, perfectly fulfilling our needs. The support we receive from Tecan is also very important in ensuring we are able to meet our commitments to clients. We have a good relationship with Tecan’s application specialists and engineers, and they are always quick to respond to our needs.”
To find out more on Tecan’s Infinite 200 PRO, visit http://www.tecan.com/infinite200
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).